Food and Drug Advanced Food and Drug Administration (FDA) approved the emergency use of the drug for the treatment of coronavirus Sotrovimab (VIR-7831) from the British company GSK (GlaxosmithKline) and the American company VIR BIOTECHNOLOGY. This is stated on the department website.
According to published post, the drug will be applied only for the treatment of adults and adolescents from 12 years, whose weight exceeds 40 kilograms if the disease occurs in a light or medium form. At the same time treat them patients who are hospitalized with virus or need oxygen therapy, prohibited.
It is noted that clinical tests of the drug are still continuing.
Previously, the US Medical Regulator approved the use of vaccine from the coronavirus company Pfizer / Biontech for adolescents aged 12 to 15 years. Acting FDA Chapter Janet Woodcock said it was a decision – an important step in the fight against the pandemic. “